Sarepta Therapeutics Inc. SRPT
$15.74
▲ +2.07% 24H
About
Sarepta Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on developing and marketing therapies for rare diseases, with a strong emphasis on genetic and neuromuscular disorders. The company’s current portfolio includes approved treatments for Duchenne muscular dystrophy, alongside research progr…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees835
TickerSRPT
Statistics
Market Cap$1.66B
Revenue (TTM)$2.20B
Net Income-$713.4M
Net Margin-32.5%
EPS$-7.13
P/E43.74
P/S0.74
P/B1.07
EV/EBITDA43.53
ROE4.9%
Dividend Yield—
Price$15.74
Data: Twelve Data · Revenue = mcap / P/S